Pfizer Loses a Round Over Marketing of Neurontin - NYTimes.com
Links shared publicly online about this topic.
- 540total visits
Pfizer Loses a Round Over Marketing of Neurontin - NYTimes.com
A judge in Boston upheld a jury decision that Pfizer illegally promoted Neurontin for unapproved uses. Pfizer said it would appeal.
View full resource at nytimes.com
Tags: Migraine Prevention Medication, Seizure, Epilepsy, Drug, Neurontin, Pfizer, Epilepsy Medication
Most Recently Shared on January 31, 2011 at 5:00 pm By:
Pfizer ordered to pay $142.1 million in violations of federal racketeering laws over marketing of epilepsy drug: http://nyti.ms/ex3Gqz
Advertisement
